AVH 0.41% $2.42 avita medical inc.

Its possible that people know sales numbers are not meeting...

  1. 1,123 Posts.
    lightbulb Created with Sketch. 1156
    Its possible that people know sales numbers are not meeting expectation this quarter and this is leading to the SP weakness.

    Another reason might be people re-calibrating their thoughts about AVH's funding situation. We've gone from:

    - AVH CFO saying we won't need the additional $50m at all; to

    - looking like AVH will need it given way higher than expected cashburn in the last two quarters; to

    - AVH may not be able to even access the funding and might have to pay back what it has already drawn down against a forced timetable due to missing the minimum revenue hurdle.

    If it got to stage 3, a capital raise will be required. Not saying this will happen, but can understand reservation about buying into AVH until the $67.5m in 2024 is in the bag.

    The problem is the CEO speaks like he's swallowed one of those positive thinking self-help books and the CFO is just a CEO-lackey who'll do and say anything he's told in order to maintain his way-above-ability salary. Makes it hard to judge the truth about likely sales performance and cashburn.

    $2.50 / share won't last long. If Q2 sales present a trajectory that makes the $67.5m likely, AVH will be back over $4 in no time. If the opposite is true, the SP could easily drop by 50% or more as AVH will be a company looking for a new management team while doing an emergency capital raise ....


 
watchlist Created with Sketch. Add AVH (ASX) to my watchlist
(20min delay)
Last
$2.42
Change
0.010(0.41%)
Mkt cap ! $160.4M
Open High Low Value Volume
$2.42 $2.45 $2.41 $562.3K 231.8K

Buyers (Bids)

No. Vol. Price($)
4 82002 $2.42
 

Sellers (Offers)

Price($) Vol. No.
$2.43 16 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.